Skip to content

Waters Corporation WAT Waters Biosciences — Labor And Related Expense

Similar metrics at other companies

CryoPort, Inc. logo
CYRXLife Sciences Products — Labor And Related Expense
$5.95M+9.5%
PTC Therapeutics logo
PTCTLife Science — Labor And Related Expense
$76.12M+12.4%
CryoPort, Inc. logo
CYRXLife Sciences Services — Labor And Related Expense
$14.86M+13.9%
Labcorp Holdings logo
LHBiopharma Laboratory Services — Labor and Related Expense
$309.3M+6.8%
Exponent logo
EXPOEnvironmental And Health — Labor And Related Expense
$12.9M+3.6%
CHE
CHELabor And Related Expense
$44.8M+3.1%

Other financials

Income statement

See full
Revenue$1.3B+91.4%
Gross profit$569.5M+8.6%
Operating income-$47.0M-131%
Net income-$72.0M-160%
EPS (diluted)-$0.87-143%

Balance sheet

See full
Cash & equivalents$462.0M+20.7%
Total debt$5.2B+263%
Total equity$15.3B+679%
Total assets$24.5B+434%

Cash flow

See full
Operating cash flow-$3.0M-101%
CapEx$39.0M+50.0%
Free cash flow-$42.0M-118%

Valuation

See full
Market cap$36.76B+78.1%
Enterprise value$41.51B+92.6%
P/E81.8×+50.6×
P/S9.8×+3.0×

Profitability

See full
Gross margin59.3%-0.1pp
Operating margin16%-12.3pp
Net margin11.9%-10.1pp
FCF margin7%-13.8pp

Returns & leverage

See full
Return on equity5.2%-35.6pp
Debt / equity0.3×-0.4×
Current ratio1.8×0.0×

Where this comes from

Reported directly by Waters Corporation in its filing.

Tagged under the XBRL concept us-gaap:LaborAndRelatedExpense.

The official record: Waters Corporation’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Waters Corporation's waters biosciences — labor and related expense.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Waters Corporation's waters biosciences — labor and related expense?
Waters Corporation (WAT) reported waters biosciences — labor and related expense of $34M in Q1 2026.
What does waters biosciences — labor and related expense mean?
This encompasses the broader category of labor-related expenses for the Biosciences segment, including both direct manufacturing labor and indirect support staff costs. It provides a comprehensive view of the human capital investment required to operate the segment.